A De-Novo drug design and ADMET study to design small molecule stabilisers targeting mutant (V210I) human prion protein against familial Creutzfeldt-Jakob disease (fCJD). - Rafat Alam; G. M. Sayedur Rahman; Nahid Hasan; Abu Sayeed Chowdhury (Int. J. Comput. Biol. Drug Des., 2020)